Tumor-specific shared antigenic peptides recognized by human T cells (Q35005926)

5 August 2017

1 reference

title

Tumor-specific shared antigenic peptides recognized by human T cells (English)

1 reference

5 August 2017

author name string

Pierre Van Der Bruggen

1 reference

5 August 2017

Yi Zhang

1 reference

5 August 2017

Pascal Chaux

1 reference

5 August 2017

Vincent Stroobant

1 reference

5 August 2017

Christophe Panichelli

1 reference

5 August 2017

Erwin S Schultz

1 reference

5 August 2017

Jacques Chapiro

1 reference

5 August 2017

Benoît J Van Den Eynde

1 reference

5 August 2017

Francis Brasseur

1 reference

5 August 2017

Thierry Boon

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

published in

Immunological Reviews

1 reference

5 August 2017

volume

188

1 reference

5 August 2017

page(s)

51-64

1 reference

Clinical cancer vaccine trials

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of a new, unorthodox member of the MAGE gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of human testis-specific transcripts and analysis of their expression in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

LAGE-1, a new gene with tumor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Serological identification of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Promiscuous and allele-specific anchors in HLA-DR-binding peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Proliferating dendritic cell progenitors in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Efficacy studies on a canarypox-rabies recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Assembly and function of type III secretory systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Degradation of cell proteins and the generation of MHC class I-presented peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

Biological and clinical developments in melanoma vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

DNA methylation changes during mouse spermatogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Production of stable cytolytic T-cell clones directed against autologous human melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Presence on a human melanoma of multiple antigens recognized by autologous CTL.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Isolation and characterization of a MAGE gene family in the Xp21.3 region

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Cloning the differences between two complex genomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Identifying differences in mRNA expression by representational difference analysis of cDNA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum− or helper peptides in priming for skin test reactivity to a P815AB‐related peptide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

The role of CD4+ T cell responses in antitumor immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Different MHC class I alleles compete for presentation of overlapping viral epitopes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18806.X

7 January 2021

10.1034/J.1600-065X.2002.18806.X

Identifiers

DOI

1 reference

5 August 2017

1 reference